Evidence map›Paper›PMID 16980409›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Aberrant MHC class II expression in mouse joints leads to arthritis with extraarticular manifestations similar to rheumatoid arthritis.

Satoshi Kanazawa, Shusuke Ota, Chiyoko Sekine, Toyohiro Tada, Takanobu Otsuka, Takashi Okamoto, Grete Sønderstrup, B Matija Peterlin

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. P-TEFb as A Promising Therapeutic Target.Molecules (Basel, Switzerland) · 2020
    Review
  11. Review
  12. Review
  13. Effect of HJournal of cellular and molecular medicine · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Satoshi KanazawaDepartments of Molecular and Cellular Biology and Musculoskeletal Medicine, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Nagoya 467-8601, Japan.
Shusuke Ota
Chiyoko Sekine
Toyohiro Tada
Takanobu Otsuka
Takashi Okamoto
Grete Sønderstrup
B Matija Peterlin
Nagoya City University · JPRIKEN Center for Integrative Medical Sciences · JPStanford University · USUniversity of California, San Francisco · US

Funding

CIITA and MHC II TranscriptionR01AI050770 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PETERLIN, BORIS MATIJA · 2003 to 2007
$1.3M
HLA DR4 TRANSGENIC MICE/ARTHRITIS MODELR01AR044647 · NIAMS · STANFORD UNIVERSITY · PI SONDERSTRUP, GRETE · 1997 to 2000
$258k
NIAID NIH HHS R01 AI 050770NIAID NIH HHS R01 AI050770NIAMS NIH HHS AR 44647
6 · The paper itself

Abstract

Genetic susceptibility to rheumatoid arthritis (RA) is associated with certain MHC class II molecules. To clarify the role of these determinants in RA, we generated the D1CC transgenic mouse that expressed genes involved in antigen processing and presentation by the MHC class II pathway in joints. The class II transactivator, which was transcribed from the rat collagen type II promoter and enhancer, directed the expression of these genes. In D1CC mice congenic for the H-2(q) (DBA/1) background, small amounts of bovine collagen type II in adjuvant induced reproducibly an inflammatory arthritis resembling RA. Importantly, these stimuli had no effect in DBA/1 mice. Eighty-nine percent of D1CC mice developed chronic disease with joint swelling, redness, and heat in association with synovial proliferation as well as pannus formation and mononuclear infiltration of synovial membranes. Granulomatous lesions resembling rheumatoid nodules and interstitial pneumonitis also were observed. As in patients with RA, anticyclic citrullinated peptide antibodies were detected during the inflammatory stage. Finally, joints in D1CC mice displayed juxtaarticular demineralization, severe joint space narrowing, and erosions, which led to ankylosis, but without the appearance of osteophytes. Thus, aberrant expression of MHC class II in joints facilitates the development of severe erosive inflammatory polyarthritis, which is very similar to RA.

Indexed as

Gene ExpressionAnimalsArthritis, ExperimentalArthritis, RheumatoidArthrographyBone DensityCattleCollagen Type IIDose-Response Relationship, DrugForelimbGenes, MHC Class IIHumansImmunizationInflammationJointsLung Diseases, InterstitialCollagen Type II

Identifiers

PMID16980409
PMCPMC1599985
OpenAlexW2093152540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.